Although some patients with CHIP do develop MDS later in their life, the pathogenesis of this condition is not yet fully understood, and so the sole presence of somatic mutations is not considered diagnostic of MDS in the cases as these. This evidence concerns the gene STUB1 and myelodysplastic syndrome.